Showing results (31-40 of 360) with videos related to

Sort By:
Pageof 36
Blood|November 16, 2002
Oncolytic measles viruses displaying a single-chain antibody against CD38, a myeloma cell markerKah-Whye Peng, Kathleen A Donovan, Urs Schneider, et al.
Molecular Therapy Oncolytics|April 28, 2016
Reporter gene imaging identifies intratumoral infection voids as a critical barrier to systemic oncolytic virus efficacyAmber Miller, Lukkana Suksanpaisan, Shruthi Naik, et al.
Molecular Therapy Oncolytics|April 28, 2016
Oncolytic potency of HER-2 retargeted VSV-FH hybrid viruses: the role of receptor ligand affinityCamilo Ayala Breton, Nitwara Wikan, Arinda Abbuhl, et al.
Molecular Cancer Therapeutics|August 28, 2020
Retargeted and Stealth-Modified Oncolytic Measles Viruses for Systemic Cancer Therapy in Measles Immune PatientsEugene S Bah, Rebecca A Nace, Kah Whye Peng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Dual therapy of ovarian cancer using measles viruses expressing carcinoembryonic antigen and sodium iodide symporterKosei Hasegawa, Linh Pham, Michael K O'Connor, et al.
The Journal of Gene Medicine|October 2, 2004
Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomasCory Allen, Cari McDonald, Caterina Giannini, et al.
Chinese Clinical Oncology|May 17, 2018
The emerging role of oncolytic virus therapy against cancerLuke Russell, Kah-Whye Peng
Molecular Therapy. Oncology|June 17, 2026
Endothelial injury is a central driver of systemic IFN-β toxicity and is reversible through Jak inhibitionLianwen Zhang, Linh Pham, Michael B Steele, et al.
Current Cancer Drug Targets|February 24, 2017
Clinical Trials with Oncolytic Measles Virus: Current Status and Future ProspectsPavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, et al.
Molecular Therapy Oncolytics|January 1, 2020
Dual-Isotope SPECT Imaging with NIS Reporter Gene and Duramycin to Visualize Tumor Susceptibility to Oncolytic Virus InfectionLianwen Zhang, Lukkana Suksanpaisan, Huailei Jiang, et al.
Pageof 36